Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Tahira Baloch"'
Autor:
Qiong Wang, Vanessa M. López‐Ozuna, Tahira Baloch, Joanne Bithras, Oreekha Amin, Roy Kessous, Liron Kogan, Ido Laskov, Amber Yasmeen
Publikováno v:
Cancer Medicine, Vol 9, Iss 4, Pp 1307-1320 (2020)
Abstract Ovarian cancer is the most lethal gynecological malignancy. Currently, new chemotherapeutic strategies are required to improve patient outcome and survival. Biguanides, classic anti‐diabetic drugs, have gained importance for theiri antitum
Externí odkaz:
https://doaj.org/article/889ca15a011e45078245990e4b24b228
Autor:
Emad Matanes, Vanessa M. López-Ozuna, David Octeau, Tahira Baloch, Florentin Racovitan, Amandeep Kaur Dhillon, Roy Kessous, Oded Raban, Liron Kogan, Shannon Salvador, Susie Lau, Walter H. Gotlieb, Amber Yasmeen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundPoly ADP-ribose glycohydrolase (PARG) is responsible for the catabolism of PARP-synthesized PAR to free ADP-ribose. Inhibition of PARG leads to DNA repair interruption and consequently induces cell death. This study aims to evaluate the eff
Externí odkaz:
https://doaj.org/article/0d9e891b94894a599e68b3cae7e6c7f2
Autor:
Tahira Baloch, Vanessa M. López-Ozuna, Qiong Wang, Emad Matanis, Roy Kessous, Liron Kogan, Amber Yasmeen, Walter H. Gotlieb
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have become the first targeted therapies available in the treatment of patients with high-grade serous ovarian cancer (HGSOC). We recently described a significant reduction in PARP1
Externí odkaz:
https://doaj.org/article/bf195635ae86487e97a9e04aa1074178
Autor:
Khaled W. Sadek, Mahmoud Y. Haik, Anas A. Ashour, Tahira Baloch, Tahar Aboulkassim, Amber Yasmeen, Semir Vranic, Asad Zeidan, Ala-Eddin Al Moustafa
Publikováno v:
Cancer Cell International, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background With the increasing popularity of water-pipe smoking (WPS), it is critical to comprehend how WPS may affect women’s health. The main goal of this study is to identify the potential outcome of WPS on human breast cancer progressi
Externí odkaz:
https://doaj.org/article/1e61122cd838426f9e569cbca95f02a4
Autor:
Charles-André Philip, Ido Laskov, Marie-Claude Beauchamp, Maud Marques, Oreekha Amin, Joanna Bitharas, Roy Kessous, Liron Kogan, Tahira Baloch, Walter H. Gotlieb, Amber Yasmeen
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background Phosphatase and Tensin homolog (PTEN) is a tumor suppressor gene. Loss of its function is the most frequent genetic alteration in endometrioid endometrial cancers (70–80%) and high grade tumors (90%). We assessed the sensitivity
Externí odkaz:
https://doaj.org/article/921f99facb7e4ba981e9e6deacfbde8f
Autor:
Florentin Racovitan, David Octeau, Emad Matanes, Liron Kogan, Amber Yasmeen, Tahira Baloch, Susie Lau, Oded Raban, Walter H. Gotlieb, Roy Kessous, Amandeep Kaur Dhillon, Shannon Salvador, Vanessa M. López-Ozuna
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundPoly ADP-ribose glycohydrolase (PARG) is responsible for the catabolism of PARP-synthesized PAR to free ADP-ribose. Inhibition of PARG leads to DNA repair interruption and consequently induces cell death. This study aims to evaluate the eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2d291f26d8ce82c933c29da4890bcce
http://europepmc.org/articles/PMC8578901
http://europepmc.org/articles/PMC8578901
Autor:
Marie-Claude Beauchamp, Ido Laskov, Roy Kessous, Joanna Bitharas, Walter H. Gotlieb, Liron Kogan, Amber Yasmeen, Maud Marques, Oreekha Amin, Tahira Baloch, Charles-André Philip
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-11 (2017)
BMC Cancer
BMC Cancer
Background Phosphatase and Tensin homolog (PTEN) is a tumor suppressor gene. Loss of its function is the most frequent genetic alteration in endometrioid endometrial cancers (70–80%) and high grade tumors (90%). We assessed the sensitivity of endom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::369d335233a8d9ac49386173419a7ac8
http://link.springer.com/article/10.1186/s12885-017-3639-0
http://link.springer.com/article/10.1186/s12885-017-3639-0
Autor:
Qiong Wang, Tahira Baloch, Ido Laskov, Oreekha Amin, Joanne Bithras, Vanessa M. López-Ozuna, Amber Yasmeen, Liron Kogan, Roy Kessous
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 4, Pp 1307-1320 (2020)
Cancer Medicine, Vol 9, Iss 4, Pp 1307-1320 (2020)
Ovarian cancer is the most lethal gynecological malignancy. Currently, new chemotherapeutic strategies are required to improve patient outcome and survival. Biguanides, classic anti‐diabetic drugs, have gained importance for theiri antitumor potenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fea1fe9a19108867a835d914921a2c54
https://pubmed.ncbi.nlm.nih.gov/31863638
https://pubmed.ncbi.nlm.nih.gov/31863638
Autor:
Qiong Wang, Liron Kogan, Roy Kessous, Tahira Baloch, Amber Yasmeen, Emad Matanis, Vanessa M. López-Ozuna, Walter H. Gotlieb
Publikováno v:
BMC Cancer
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Cancer, Vol 19, Iss 1, Pp 1-9 (2019)
Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have become the first targeted therapies available in the treatment of patients with high-grade serous ovarian cancer (HGSOC). We recently described a significant reduction in PARP1 protein l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a74898895dec763feda7409b7a0d39
https://doi.org/10.1186/s12885-018-5250-4
https://doi.org/10.1186/s12885-018-5250-4
Autor:
Emad Matanes, Tahira Baloch, N. Eisenberg, Susie Lau, Cristina Mitric, Vanessa M. López-Ozuna, Oded Raban, W.H. Gotlieb, Shannon Salvador, Amber Yasmeen, Liron Kogan
Publikováno v:
Gynecologic Oncology. 159:137
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0d26d5522da7a5dff30f1808a5b6cc9
https://doi.org/10.1016/j.ygyno.2020.05.177
https://doi.org/10.1016/j.ygyno.2020.05.177